The fusion protein of streptavidin to aequorin (STA-AQ) was highly purified from inclusion bodies in Escherichia coli cells and applied to a bioluminescent sandwich immunoassay. α-Fetoprotein (AFP), which is a serological marker of liver cancer, was used as a model analyte to test STA-AQ in an immunoassay. The measurable range of AFP by the sandwich immunoassay, using the complex of STA-AQ and the biotinylated anti-AFP antibody, was 0.02-200 ng/mL with an average coefficient of variation of 4.9%. The detection sensitivity with the complex of STA-AQ and the biotinylated anti-AFP antibody was similar to that with the complex of biotinylated aequorin, streptavidin and the biotinylated anti-AFP antibody. STA-AQ would be a useful reporter protein for immunoassays.
CITATION STYLE
Inouye, S., Sato, J. I., Sasaki, S., & Sahara, Y. (2011). Streptavidin-aequorin fusion protein for bioluminescent immunoassay. Bioscience, Biotechnology and Biochemistry, 75(3), 568–571. https://doi.org/10.1271/bbb.100798
Mendeley helps you to discover research relevant for your work.